N/A
NPS Score
VS
MyoKardia Claimed Company
- EMPLOYEE
PARTICIPANTS - 2
- TOTAL
RATINGS
Recursion Claimed Company
- EMPLOYEE
PARTICIPANTS - 35
- TOTAL
RATINGS
MyoKardia vs Recursion
Competitors at MyoKardia is not yet available. Get insights into the competitive rankings of MyoKardia CEO Rating, Culture Score, Brand Ranking, and other rankings soon.
MyoKardia
MyoKardia's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of MyoKardia. Their current market cap is $11.99B.
Recursion
Recursion's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Recursion. Their current valuation is $650.00M.
4/5
Product Quality
3.4/5
4/5
Pricing
3.6/5
4/5
Customer Service
3.8/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
22
NPS Score
| 52% | Promoters |
|---|---|
| 18% | Passive |
| 30% | Detractors |
Net Promoter Score
Winner by 22
See how MyoKardia compares to its competitors
Working at MyoKardia vs Working at Recursion
Not enough ratings
CEO Rating
84 / 100
CEO Rating
Winner
MyoKardia
MyoKardia doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Recursion
Employees at Recursion rate their CEO, Christopher Gibson, 84/100.